Skip to Content
Merck
CN
  • Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma.

Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma.

PloS one (2020-09-10)
Lluc Farrera-Soler, Jean-Pierre Daguer, Sofia Barluenga, Oscar Vadas, Patrick Cohen, Sabrina Pagano, Sabine Yerly, Laurent Kaiser, Nicolas Vuilleumier, Nicolas Winssinger
ABSTRACT

A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) is the source of a current pandemic (COVID-19) with devastating consequences in public health and economic stability. Using a peptide array to map the antibody response of plasma from healing patients (12) and heathy patients (6), we identified three immunodominant linear epitopes, two of which correspond to key proteolytic sites on the spike protein (S1/S2 and S2') known to be critical for cellular entry. We show biochemical evidence that plasma positive for the epitope adjacent to the S1/S2 cleavage site inhibits furin-mediated proteolysis of spike.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidine, ≥99%
Sigma-Aldrich
Streptavidin from Streptomyces avidinii, recombinant, expressed in E. coli, lyophilized powder